Orange County NC Website
Browse       Search
Revised -XO\ <br />EC 11: Hepatitis B Vaccine and Post-Exposure Evaluation and Follow Up (Continued): <br />•Information Provided To The Healthcare Professional: <br />o The County/Entity Bloodborne Pathogens Coordinator shall ensure that <br />the healthcare professional responsible for the employee's Hepatitis B <br />vaccination is provided with the following: <br />A copy of the OSHA Bloodborne Pathogens Standard, 29 CFR <br />1910.1030; (While the standard outlines the confidentiality <br />requirements of the healthcare professional, the County/Entity <br />Bloodborne Pathogens Coordinator is to remind the healthcare <br />professional of these requirements) <br />A written description of the exposed employee's duties as they <br />relate to the exposure incident; <br />Written documentation of the route of exposure and circumstances <br />under which exposure occurred; <br />Results of the source individual's blood testing, if available; and <br />All medical records relevant to the appropriate treatment of the <br />employee including vaccination status. <br />•Healthcare Professional's Written Opinion: <br />o The County/Entity Bloodborne Pathogens Coordinator shall obtain and <br />provide the employee with a copy of the evaluating healthcare <br />professional's written opinion within 15 days of the completion of the <br />evaluation. <br />o The healthcare professional's written opinion for HBV vaccination shall be <br />limited to whether HBV vaccination is indicated for an employee, and if the <br />employee has received such vaccination. <br />o The healthcare professional's written opinion for post exposure follow-up <br />shall be limited to the following information: <br />A statement that the employee has been informed of the results of <br />the evaluation; and <br />A statement that the employee has been told about any medical <br />conditions resulting from exposure to blood or other potentially <br />infectious materials which require further evaluation or treatment. <br />NOTE: All other findings or diagnosis shall remain confidential and shall not be <br />included in the written report. <br />DocuSign Envelope ID: 79C5D167-B6CA-4E59-B4AC-AA38CC1B20BD